Efficacy of Liposomal Bupivacaine Post Septorhinoplasty

NCT05964868 · clinicaltrials.gov ↗

PHASE3

Phase

ENROLLING_BY_INVITATION

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Rhinoplasty
Pain Management

Interventions

DRUG: Liposomal Bupivacaine
DRUG: 0.25% bupivacaine with 1:200,000 epinephrine
OTHER: Placebo - Saline solution

Sponsor

Jessyka Lighthall